What does momenta Pharmaceuticals do?
Momenta is a biotechnology company with a validated innovative scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases. Our scientific foundation is based on a deep understanding of immune biology and disease analytics.
Who owns amphastar pharmaceuticals?
The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.
When did amphastar go public?
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products.
Who acquired Momenta?
Johnson & Johnson
NEW BRUNSWICK, N.J., October 1, 2020 — Johnson & Johnson (NYSE: JNJ) today announced it has successfully completed its acquisition of Momenta Pharmaceuticals, Inc. (“Momenta”), a company that discovers and develops novel therapies for immune-mediated diseases, in an all cash transaction for approximately $6.5 billion.
Why did J&J buy Momenta?
When first announcing the agreement to acquire Momenta, Johnson & Johnson said it saw the purchase as an opportunity for its Janssen Pharmaceutical subsidiary to broaden its work in immune-mediated disease and drive growth through expansion into autoantibody-driven diseases.
Who makes narcan stock?
Opiant
Corporate Profile. Opiant is a specialty pharmaceutical company developing medicines for addiction and drug overdose. The Company developed NARCAN® (naloxone hydrochloride) Nasal Spray (“NARCAN®”), a treatment to reverse opioid overdose.
Why did Johnson and Johnson acquire momenta?
The acquisition was driven by the significant opportunity seen in nipocalimab, along with the scientific capability Janssen is acquiring with the Momenta team. Janssen’s plans for additional assets in the Momenta pipeline will be determined as more data become available and could offer further upside potential.
When did Johnson and Johnson acquire momenta?
October 1, 2020
The acquisition was completed on October 1, 2020 through a merger of Vigor with and into Momenta in accordance with Section 251(h) of the General Corporation Law of the State of Delaware without a vote of Momenta’s stockholders. Momenta now operates as a wholly-owned subsidiary of Johnson & Johnson.
When did Johnson acquire Janssen?
1961
1961. Janssen Pharmaceutica was acquired by Johnson & Johnson, bringing to the company Janssen’s strong capabilities in the growing field of pharmaceutical medicines. For Dr Paul Janssen, the global reach of Johnson & Johnson would enable him and his colleagues to help more patients.
Which Pharma makes Narcan?
Adapt Pharma
We were founded in 2009. In 2013, Opiant developed the first FDA-approved, user-friendly nasal naloxone spray. In 2015 this product, NARCAN® Nasal Spray 4mg, became available in the United States and Canada through our commercial partner, Adapt Pharma (now a part of Emergent BioSolutions).
When was Narcan made?
Naloxone was patented in 1961 by Mozes J. Lewenstein, Jack Fishman, and the company Sankyo. It was approved for opioid use disorder treatment in the United States in 1971, with opioid overdose prevention kits being distributed by many states to medically untrained people beginning in 1996.
When did J&J acquire momenta?
https://www.youtube.com/watch?v=fW9Vo5KSHMk